Artwork

Content provided by KGNU - How On Earth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGNU - How On Earth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Clinical Trials Test MDMA as PTSD Treatment

27:08
 
Share
 

Manage episode 171395300 series 49299
Content provided by KGNU - How On Earth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGNU - How On Earth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Artwork credit: MDMA trial participant Allison Heistand-Phelps
Artwork credit: MDMA trial participant Allison Heistand-Phelps

This week on How on Earth host Susan Moran interviews two investigators of FDA-approved clinical trials testing the efficacy and safety of the illegal drug MDMA — known in an altered form as Ecstasy or Molly — as a treatment (along with psychotherapy sessions) for Post-Traumatic Stress Syndrome. Our guests are Marcela Ot’alora and Bruce Poulter, investigators of the Colorado trial. Marcela is a licensed psychotherapist and Bruce is a registered nurse with a masters degree in public health

PTSD is an anxiety disorder that affects up to one in 12 people in the United States, and it’s at least as common in some other countries. It is a serious, and costly, public health problem. If the trials are successful, MDMA, which has its critics, could become commercially available as a medically prescribed treatment by 2021. The trials are being funded by a nonprofit organization, the Multidisciplinary Association for Psychedelic Studies (MAPS), which promotes careful and beneficial uses of psychedelics and marijuana.

Hosts: Susan Moran, Joel Parker
Producer: Susan Moran
Engineer: Joel Parker
Executive Producer: Joel Parker

Listen to the show:

  continue reading

654 episodes

Artwork
iconShare
 
Manage episode 171395300 series 49299
Content provided by KGNU - How On Earth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KGNU - How On Earth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Artwork credit: MDMA trial participant Allison Heistand-Phelps
Artwork credit: MDMA trial participant Allison Heistand-Phelps

This week on How on Earth host Susan Moran interviews two investigators of FDA-approved clinical trials testing the efficacy and safety of the illegal drug MDMA — known in an altered form as Ecstasy or Molly — as a treatment (along with psychotherapy sessions) for Post-Traumatic Stress Syndrome. Our guests are Marcela Ot’alora and Bruce Poulter, investigators of the Colorado trial. Marcela is a licensed psychotherapist and Bruce is a registered nurse with a masters degree in public health

PTSD is an anxiety disorder that affects up to one in 12 people in the United States, and it’s at least as common in some other countries. It is a serious, and costly, public health problem. If the trials are successful, MDMA, which has its critics, could become commercially available as a medically prescribed treatment by 2021. The trials are being funded by a nonprofit organization, the Multidisciplinary Association for Psychedelic Studies (MAPS), which promotes careful and beneficial uses of psychedelics and marijuana.

Hosts: Susan Moran, Joel Parker
Producer: Susan Moran
Engineer: Joel Parker
Executive Producer: Joel Parker

Listen to the show:

  continue reading

654 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide